Mary Thompson

Executive Editor, MedTech Strategist

25 Years of Experience

About

A founding member of the MedTech Strategist editorial team, @MaryThompsonMTS has 25+ years of experience covering technologies and trends in the medical device industry. She currently focuses on the cardiovascular, diabetes, and digital health markets. Prior to joining MedTech Strategist, Mary was Managing Editor/Executive Editor of the Medtech Insight Newsletter, a position she held for nearly 14 years, and she was instrumental in the initial conceptualization and launch of that publication. Mary’s extensive editorial experience combined with her early background as an R&D scientist brings a unique balance of expertise and perspective to her work.

Articles from Mary Thompson:

Business Strategies

Think PCI Innovation Is Tapped Out? Elixir Medical Says Think Again

Elixir Medical hopes to raise the bar for percutaneous coronary Intervention (PCI) with its DynamX Coronary Bioadaptor System, an innovative implant that opens and supports a diseased coronary artery without permanently caging the vessel. DynamX recently outperformed a state-of-the-art drug-eluting stent in a randomized, head-to-head comparison.

Read Article